Literature DB >> 10391144

Increased peroxisomal fatty acid beta-oxidation and enhanced expression of peroxisome proliferator-activated receptor-alpha in diabetic rat liver.

K Asayama1, R Sandhir, F G Sheikh, H Hayashibe, T Nakane, I Singh.   

Abstract

To determine whether the increased fatty acid beta-oxidation in the peroxisomes of diabetic rat liver is mediated by a common peroxisome proliferation mechanism, we measured the activation of long-chain (LC) and very long chain (VLC) fatty acids catalyzed by palmitoyl CoA ligase (PAL) and lignoceryl CoA ligase and oxidation of LC (palmitic acid) and VLC (lignoceric acid) fatty acids by isotopic methods. Immunoblot analysis of acyl-CoA oxidase (ACO), and Northern blot analysis of peroxisome proliferator-activated receptor (PPAR-alpha), ACO, and PAL were also performed. The PAL activity increased in peroxisomes and mitochondria from the liver of diabetic rats by 2.6-fold and 2.1 -fold, respectively. The lignoceroyl-CoA ligase activity increased by 2.6-fold in diabetic peroxisomes. Palmitic acid oxidation increased in the diabetic peroxisomes and mitochondria by 2.5-fold and 2.7-fold, respectively, while lignoceric acid oxidation increased by 2.0-fold in the peroxisomes. Immunoreactive ACO protein increased by 2-fold in the diabetic group. The mRNA levels for PPAR-alpha, ACO and PAL increased 2.9-, 2.8- and 1.6-fold, respectively, in the diabetic group. These results suggest that the increased supply of fatty acids to liver in diabetic state stimulates the expression of PPAR-alpha and its target genes responsible for the metabolism of fatty acids.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391144     DOI: 10.1023/a:1006930513476

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  43 in total

1.  Factors influencing the rates of long-chain fatty acid oxidation and synthesis in mammalian systems.

Authors:  I B FRITZ
Journal:  Physiol Rev       Date:  1961-01       Impact factor: 37.312

2.  Tissue fractionation studies. 15. Intracellular distribution and properties of beta-N-acetylglucosaminidase and beta-galactosidase in rat liver.

Authors:  O Z SELLINGER; H BEAUFAY; P JACQUES; A DOYEN; C DE DUVE
Journal:  Biochem J       Date:  1960-03       Impact factor: 3.857

3.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.

Authors:  I Issemann; S Green
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

4.  Involvement of calmodulin- and protein kinase C-related mechanism in an induction process of peroxisomal fatty acid oxidation-related enzymes by hypolipidemic peroxisome proliferators.

Authors:  T Watanabe; S Okawa; H Itoga; T Imanaka; T Suga
Journal:  Biochim Biophys Acta       Date:  1992-04-30

Review 5.  beta-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of continued progress.

Authors:  W H Kunau; V Dommes; H Schulz
Journal:  Prog Lipid Res       Date:  1995       Impact factor: 16.195

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Effect of cyclodextrins on the solubilization of lignoceric acid, ceramide, and cerebroside, and on the enzymatic reactions involving these compounds.

Authors:  I Singh; Y Kishimoto
Journal:  J Lipid Res       Date:  1983-05       Impact factor: 5.922

8.  Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy.

Authors:  I Singh; A E Moser; S Goldfischer; H W Moser
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

Review 9.  Substituted 2-oxiranecarboxylic acids: a new group of candidate hypoglycaemic drugs.

Authors:  P L Selby; H S Sherratt
Journal:  Trends Pharmacol Sci       Date:  1989-12       Impact factor: 14.819

10.  Proliferation of myocardial peroxisomes in experimental rat diabetes: a biochemical and immunocytochemical study.

Authors:  S Yokota; K Asayama
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1992
View more
  20 in total

Review 1.  Peroxisomal acyl-CoA synthetases.

Authors:  Paul A Watkins; Jessica M Ellis
Journal:  Biochim Biophys Acta       Date:  2012-02-17

2.  Identification of type 2 diabetes subgroups through topological analysis of patient similarity.

Authors:  Li Li; Wei-Yi Cheng; Benjamin S Glicksberg; Omri Gottesman; Ronald Tamler; Rong Chen; Erwin P Bottinger; Joel T Dudley
Journal:  Sci Transl Med       Date:  2015-10-28       Impact factor: 17.956

3.  Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model.

Authors:  R Scott Rector; Grace M Uptergrove; E Matthew Morris; Sarah J Borengasser; M Harold Laughlin; Frank W Booth; John P Thyfault; Jamal A Ibdah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-24       Impact factor: 4.052

4.  The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus.

Authors:  Brian N Finck; John J Lehman; Teresa C Leone; Michael J Welch; Michael J Bennett; Attila Kovacs; Xianlin Han; Richard W Gross; Ray Kozak; Gary D Lopaschuk; Daniel P Kelly
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

5.  Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor-β.

Authors:  Malabendu Jana; Susanta Mondal; Frank J Gonzalez; Kalipada Pahan
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

6.  Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling.

Authors:  Andrew D Patterson; Olivier Maurhofer; Diren Beyoglu; Christian Lanz; Kristopher W Krausz; Thomas Pabst; Frank J Gonzalez; Jean-François Dufour; Jeffrey R Idle
Journal:  Cancer Res       Date:  2011-09-07       Impact factor: 12.701

7.  Peroxisome proliferator-activated receptor {alpha} is responsible for the up-regulation of hepatic glucose-6-phosphatase gene expression in fasting and db/db Mice.

Authors:  Seung-Soon Im; Mi-Young Kim; Sool-Ki Kwon; Tae-Hyun Kim; Jin-Sik Bae; Hail Kim; Kyung-Sup Kim; Goo-Taeg Oh; Yong-Ho Ahn
Journal:  J Biol Chem       Date:  2010-11-16       Impact factor: 5.157

8.  Overexpression of c-myc in diabetic mice restores altered expression of the transcription factor genes that regulate liver metabolism.

Authors:  Efren Riu; Tura Ferre; Alex Mas; Antonio Hidalgo; Sylvie Franckhauser; Fatima Bosch
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

9.  Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice.

Authors:  Vijay K Yechoor; Mary-Elizabeth Patti; Robert Saccone; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

Review 10.  Mitochondrial trifunctional protein defects: clinical implications and therapeutic approaches.

Authors:  R Scott Rector; R Mark Payne; Jamal A Ibdah
Journal:  Adv Drug Deliv Rev       Date:  2008-07-04       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.